Navigation Links
MiMedx Group, Inc. Announces Release Date for 2012 Fourth Quarter Results
Date:2/7/2013

KENNESAW, Ga., Feb. 7, 2013 /PRNewswire/ -- MiMedx Group, Inc. (OTC: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the fourth quarter ended December 31, 2012, will be released before the opening of the market on Thursday, March 7, 2013. MiMedx will host a live broadcast of its fourth quarter conference call on Thursday, March 7, 2013 at 10:30 AM EST. A listen-only simulcast of the MiMedx Group conference call will be available online at the Company's website at www.mimedx.com or at www.earnings.com. A 30-day online replay will be available approximately one hour following the conclusion of the live broadcast. The replay can also be found on the Company's website at www.mimedx.com or www.earnings.com.

About the Company

MiMedx® is an integrated developer, manufacturer and marketer of patent protected regenerative biomaterial products and bioimplants processed from human amniotic membrane. "Innovations in Regenerative Biomaterials" is the framework behind our mission to give physicians products and tissues to help the body heal itself. Our biomaterial platform technologies include the device technologies HydroFix® and CollaFix™, and our tissue technologies, AmnioFix® and EpiFix®. Our tissue technologies are processed from human amniotic membrane that is derived from the donated placentas. Through our donor program, mothers delivering full-term Caesarean section births can elect in advance of delivery to donate the placenta in lieu of having it discarded as medical waste. We process the human amniotic membrane utilizing our proprietary Purion® Process, to produce a safe, effectiv
'/>"/>

SOURCE MiMedx Group, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. MiMedx Group to Present at the Canaccord Genuity Medical Technology & Diagnostics Forum
2. MiMedx Group Announces Record Third Quarter Results And Raises Revenue Estimates For The Year
3. MiMedx Group to Present at the Craig-Hallum 2012 Alpha Select Conference
4. MiMedx Group to Present at the BIOX; Noble Financial Capital Markets Life Sciences Exposition
5. MiMedx Group Raises over $4.9 Million through the Exercise of Callable Warrants
6. MiMedx Group to Present at the Canaccord Genuity Annual Growth Conference
7. MiMedx Group Announces Record Second Quarter Results
8. MiMedx Group, Inc. Announces Release Date for 2012 Second Quarter Results
9. MiMedx Group Announces Record First Quarter Results
10. MiMedx Exceeds Revenue Goal for First Quarter of 2012
11. MiMedx Signs Agreement with Systagenix for Global Distribution of EpiFix®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... YORK , September 2, 2014 ... Study on Membrane Technology in Pharmaceutical, Biopharma and Life ... Highest Growth by 2019" the global membrane technology market for pharmaceutical, ... million in 2014 and is expected to grow at ... reach an estimated value of USD 10,886.0 million in ...
(Date:9/2/2014)... Sept. 2, 2014  TransCelerate BioPharma Inc. ("TransCelerate") ... approach for protecting personal data in Clinical Study ... and others. The document describes an approach to ... CSRs and other related clinical trial documents, and ... goal of the TransCelerate CSR Redaction approach is ...
(Date:9/2/2014)... -- Technology Applications International Corporation (the "Company" or "NUUU")(OTC BB: ... Inc. has signed an additional exclusive licensing agreement with ... Johnson Space Center in Houston , ... Charles J. Scimeca , NUUU,s ... latest, exclusive agreement with NASA. In addition to our ...
(Date:9/2/2014)... Myriant Corporation, a global renewable chemicals ... agreement with Azelis Group, a specialty chemicals distribution ... in the Nordics, Benelux, France, Iberia, Italy, the ... industrial and base chemicals markets. , “As a ... chemical portfolio with extensive distribution networks providing Myriant ...
Breaking Biology Technology:Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 2Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 3Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 4Global Membrane Technology Market Will Reach $10,886.0 Million in 2019: Persistence Market Research 5TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 2TransCelerate BioPharma Inc. Releases Recommended Approach for Protecting Personal Data in Clinical Study Reports 3Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 2Technology Applications International Corporation Subsidiary Enters Into Additional Exclusive Agreement with NASA at a Signing Ceremony at the Johnson Space Center In Houston, Texas 3Myriant and Azelis Sign European Distribution Agreement for Bio-Succinic Acid 2
... Centre leads the way in harnessing private sector for agricultural innovation , ... VINELAND, ON , June 30 ... today issued a response to the G20,s Communiqué to "Harness the private sector ... , , ...
... STOCKHOLM , June 30, 2010 , ... - Agreement Marks Milestone in Pharmalink,s Corporate ... Pharmalink AB, today ... Xepol(R) programme for the,treatment of post-polio syndrome (PPS). The parties had previously announced,reaching an ...
... Danish scientists have used Computer Tomography (CT) and Magnetic ... including alligators, snakes and tarantulas. Images revealed, for ... internal organs in preparation for a big meal and ... scientists think MRI and CT images of animal anatomy ...
Cached Biology Technology:Vineland shows Canadian leadership with response to G20 2Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome 2Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome 3Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome 4Pharmalink AB Closes Deal With Grifols SA for the Acquisition of the Xepol(R) Programme for the Treatment of Post-Polio Syndrome 5Feast and famine: MRI reveals secrets of animal anatomy 2
(Date:9/2/2014)... hard to comprehend how bad the current rate of ... what it was before people came along. The newest ... lower than scientists had thought, which means that the ... about 1,000 times more frequent now than in the ... from lead author Jurriaan de Vos, a Brown University ...
(Date:9/2/2014)... of the University of Granada has revealed new data ... Iberian Peninsula around the mid Holocene (around 6.000 years ... the Sahara increased. The data came from a study ... Sierra Nevada (Granada) , This study, published in the ... sedimentation of atmospheric dust from the Sahara, a very ...
(Date:9/2/2014)... that professional baseball pitchers with poor core stability are more ... season because of injury than are pitchers who have good ... In the study, 347 pitchers were assessed for lumbopelvic control ... as they raised a leg to step up were up ... days cumulative, not consecutive during the season than ...
Breaking Biology News(10 mins):Extinctions during human era worse than thought 2Extinctions during human era worse than thought 3Scientists obtain new data on the weather 10,000 years ago from sediments of a lake in Sierra Nevada 2In pro baseball pitchers, weak core linked to more missed days 2In pro baseball pitchers, weak core linked to more missed days 3
... is to fund research exploring the link between Bisphenol A ... heart disease. The grant is for 119,169. In the ... have suggested that some manmade chemicals might be linked to ... used in some types of plastic containers. A ...
... An award-winning nature essay, written during a USDA Forest ... for nature writing. The essay, "Mind in the Forest," ... Indiana University, stresses the author,s connection with nature, especially ... issue of how humans engage with the natural world. ...
... Plants respond to attacks by herbivores or pathogens by ... the attackers. These defense responses require a great deal ... be invested in growth and reproduction. So, it,s very ... Hormones, such as the jasmonates, are crucial in this ...
Cached Biology News:Nature essay made possible by Forest Service program, is Orion Magazine selection 2Biologists discover an on/off button on plants' alarm system 2
... For nucleofection of optimized cell lines in ... the nucleofection parameters. Nucleofector Kits are only ... Different cell lines can be transfected with ... are given in brackets in percent (Efficiency ...
... Human Pathogenic Viruses The National ... preserves well characterised, authenticated human ... facility, and NCPV is able ... nucleic acids derived from them, ...
B-FABP (FL-132)...
... a highly purified preparation of the catalytic ... which recognizes the identical cleavage site as ... enzymatic activity (1). Novagen&'s enzyme is produced ... the highest activity available, and is qualified ...
Biology Products: